Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mazza, Giuseppe ^a   Rombouts, Krista ^a   Rennie Hall, Andrew ^a   Urbani, Luca ^a   Vinh Luong, Tu ^a   Al Akkad, Walid ^a   Longato, Lisa ^a   Brown, David ^a   Maghsoudlou, Panagiotis ^b   Dhillon, Amar P ^a   Fuller, Barry ^a   Davidson, Brian ^a   Moore, Kevin ^a   Dhar, Dipok ^a   De Coppi, Paolo ^a   Malago, Massimo ^a   Pinzani, Massimo ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOENGINEERING; BIOMEDICAL ENGINEERING; C57BL MOUSE; CYTOLOGY; EXTRACELLULAR MATRIX; HEP-G2 CELL LINE; HEPATIC STELLATE CELL; HEPATOBLASTOMA; HUMAN; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING; TISSUE SCAFFOLD; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BIOENGINEERING; BIOMEDICAL ENGINEERING; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; HEP G2 CELLS; HEPATIC STELLATE CELLS; HEPATOBLASTOMA; HEPATOCYTES; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84938855249     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13079     Document Type: Article

References (35)

1. Murray, C. J. L. & Lopez, A. D. Measuring the Global Burden of Disease. N. Engl. J. Med. 369, 448-457, doi: 10.1056/ NEJMra1201534 (2013).
2. BASL & BSG. A Time Act: Improving Liver Health and Outcomes in Liver Disease (2009).
3. Dutkowski, P. et al. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl. 17, 674-684, doi: 10.1002/lt.22228 (2011).
4. Brown, K. A. Liver transplantation. Curr Opin Gastroenterol 21, 331-336 (2005).
5. Busuttil, R. W. & Tanaka, K. The utility of marginal donors in liver transplantation. Liver Transpl. 9, 651-663, doi: 10.1053/ jlts.2003.50105 (2003).
6. Fox, I. J. et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338, 1422-1426, doi: 10.1056/nejm199805143382004 (1998).
7. Dhawan, A. et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78, 1812-1814 (2004).
8. Muraca, M. et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359, 317-318, doi: 10.1016/s0140-6736(02)07529-3 (2002).
9. Sokal, E. M. et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76, 735-738, doi: 10.1097/01.tp.0000077420.81365.53 (2003).
10. Horslen, S. P. et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111, 1262-1267 (2003).
11. Struecker, B., Raschzok, N. & Sauer, I. M. Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol 11, 166-176, doi: 10.1038/nrgastro.2013.204 (2014).
12. NHS. Organ Donation and Transplantation Activity Report 2013/14, (2014) Available at: https://nhsbtmediaservices.blob.core. windows.net/organ-donation-assets/pdfs/activity-report-2013-14.pdf (Accessed: 16th October 2014).
13. Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch. Toxicol. 87, 1315-1530, doi: 10.1007/s00204-013-1078-5 (2013).
14. Ren, H. et al. Evaluation of two decellularization methods in the development of a whole-organ decellularized rat liver scaffold. Liver Int 33, 448-458, doi: 10.1111/liv.12088 (2013).
15. Pan, M. X. et al. An efficient method for decellularization of the rat liver. J. Formos. Med. Assoc. 113, 680-687, doi: 10.1016/j. jfma.2013.05.003 (2014).
16. Nari, G. A. et al. Preparation of a three-dimensional extracellular matrix by decellularization of rabbit livers. Rev. Esp. Enferm. Dig. 105, 138-143 (2013).
17. Kajbafzadeh, A. M., Javan-Farazmand, N., Monajemzadeh, M. & Baghayee, A. Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. Tissue Eng Part C Methods 19, 642-651, doi: 10.1089/ten.TEC.2012.0334 (2013).
18. Wang, Y. et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 53, 293-305, doi: 10.1002/hep.24012 (2011).
19. Soto-Gutierrez, A. et al. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods 17, 677-686, doi: 10.1089/ten.tec.2010.0698 (2011).
20. Uygun, B. E. et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 16, 814-820, doi: 10.1038/nm.2170 (2010).
21. Barakat, O. et al. Use of decellularized porcine liver for engineering humanized liver organ. J. Surg. Res. 173, e11-e25, doi: 10.1016/j.jss.2011.09.033 (2012).
22. Totonelli, G. et al. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials 33, 3401-3410, doi: 10.1016/j.biomaterials.2012.01.012 (2012).
23. Quint, C. et al. Decellularized tissue-engineered blood vessel as an arterial conduit. Proceedings of the National Academy of Sciences 108, 9214-9219, doi: doi: 10.1073/pnas.1019506108 (2011).
24. Lin, P., Chan, W. C., Badylak, S. F. & Bhatia, S. N. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng. 10, 1046-1053, doi: 10.1089/ten.2004.10.1046 (2004).
25. Baptista, P. M. et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 53, 604-617, doi: 10.1002/hep.24067 (2011).
26. Halliday, P., Sheil, A. G. R., Bookllil, M. J. & Gaudry, P. L. Preparation of the Porcine Liver for Allotransplantation. Aust. N. Z. J. Surg. 40, 374-380, doi: 10.1111/j.1445-2197.1971.tb04097.x (1971).
27. Orlando, G. et al. Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies. Biomaterials 34, 5915-5925, doi: 10.1016/j.biomaterials.2013.04.033 (2013).
28. Guyette, J. P. et al. Perfusion decellularization of whole organs. Nat. Protocols 9, 1451-1468, doi: 10.1038/nprot.2014.097 (2014).
29. Gilpin, S. E. et al. Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale. J. Heart Lung Transplant. 33, 298-308, doi: 10.1016/j.healun.2013.10.030 (2014).
30. Baptista, P. M., Vyas, D., Moran, E., Wang, Z. & Soker, S. Human liver bioengineering using a whole liver decellularized bioscaffold. Methods Mol. Biol. 1001, 289-298, doi: 10.1007/978-1-62703-363-3-24 (2013).
31. Agency, E. M. Reflection paper on classification of advanced therapy medicinal products, (2012) Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2012/12/WC500136422.pdf (Accessed: 16th October 2014).
32. Mirmalek-Sani, S. H., Sullivan, D. C., Zimmerman, C., Shupe, T. D. & Petersen, B. E. Immunogenicity of decellularized porcine liver for bioengineered hepatic tissue. Am. J. Pathol. 183, 558-565, doi: 10.1016/j.ajpath.2013.05.002 (2013).
33. Xu, L. et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54, 142-151, doi: 10.1136/gut.2004.042127 (2005).
34. Cheng, Y. et al. In vitro culture of tumour-derived hepatocytes in decellularised whole-liver biological scaffolds. Digestion 87, 189-195, doi: 10.1159/000349949 (2013).
35. Pan, T. L. et al. Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cells. J. Proteomics 75, 4676-4692, doi: 10.1016/j.jprot.2012.02.017 (2012).